Detection of plasmid DNA vectors following gene transfer to the murine airways

被引:40
作者
Pringle, IA
Raman, S
Sharp, WW
Cheng, SH
Hyde, SC
Gill, DR
机构
[1] Univ Oxford, John Radcliffe Hosp, Genemed Res Grp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England
[2] United Kingdom Cyst Fibrosis Gene Therapy Consort, Oxford, England
[3] Univ Oxford, Inst Mol Med, ATR X Res Grp, Oxford, England
[4] Genzyme Corp, Cambridge, MA USA
基金
英国医学研究理事会;
关键词
gene transfer; plasmid DNA; lung gene expression; de novo methylation;
D O I
10.1038/sj.gt.3302518
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-viral gene therapy is being considered as a treatment for cystic fibrosis. In clinical studies and in studies using the mouse airways as a model, current formulations result in only transient transgene expression. A number of reasons for this have been proposed including the loss of plasmid DNA from cells. The aim of these studies was to investigate why transgene expression from non-viral vectors is transient in the mouse lung. Plasmid DNA encoding the luciferase reporter gene was complexed with the cationic lipid GL67 and delivered to the mouse airways. The persistence of plasmid DNA in the mouse lungs was investigated using quantitative PCR and Southern hybridization. Results showed that intact plasmid DNA persisted in the mouse lung in the absence of any detectable luciferase activity. The de novo methylation of plasmid DNA in vivo was investigated as a potential cause of this transient gene expression but results suggested that plasmid DNA does not become de novo methylated in the mouse lung. Therefore processes other than the loss of plasmid DNA from the lung or the de novo methylation of plasmid DNA vectors must be responsible for the transient transgene expression.
引用
收藏
页码:1206 / 1214
页数:9
相关论文
共 47 条
  • [1] Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis:: a double-blind placebo-controlled trial
    Alton, EWFW
    Stern, M
    Farley, R
    Jaffe, A
    Chadwick, SL
    Phillips, J
    Davies, J
    Smith, SN
    Browning, J
    Davies, MG
    Hodson, ME
    Durham, SR
    Li, D
    Jeffery, PK
    Scallan, M
    Balfour, R
    Eastman, SJ
    Cheng, SH
    Smith, AE
    Meeker, D
    Geddes, DM
    [J]. LANCET, 1999, 353 (9157) : 947 - 954
  • [2] NONINVASIVE LIPOSOME-MEDIATED GENE DELIVERY CAN CORRECT THE ION-TRANSPORT DEFECT IN CYSTIC-FIBROSIS MUTANT MICE
    ALTON, EWFW
    MIDDLETON, PG
    CAPLEN, NJ
    SMITH, SN
    STEEL, DM
    MUNKONGE, FM
    JEFFERY, PK
    GEDDES, DM
    HART, SL
    WILLIAMSON, R
    FASOLD, KI
    MILLER, AD
    DICKINSON, P
    STEVENSON, BJ
    MCLACHLAN, G
    DORIN, JR
    PORTEOUS, DJ
    [J]. NATURE GENETICS, 1993, 5 (02) : 135 - 142
  • [3] Effect of the E4 region on the persistence of transgene expression from adenovirus vectors
    Armentano, D
    Zabner, J
    Sacks, C
    Sookdeo, CC
    Smith, MP
    StGeorge, JA
    Wadsworth, SC
    Smith, AE
    Gregory, RJ
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (03) : 2408 - 2416
  • [4] PURIFICATION AND FUNCTIONAL RECONSTITUTION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR)
    BEAR, CE
    LI, CH
    KARTNER, N
    BRIDGES, RJ
    JENSEN, TJ
    RAMJEESINGH, M
    RIORDAN, JR
    [J]. CELL, 1992, 68 (04) : 809 - 818
  • [5] BRONDYK B, 1994, PROMEGA NOTES, V49, P7
  • [6] Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver
    Chen, ZY
    Yant, SR
    He, CY
    Meuse, L
    Shen, S
    Kay, MA
    [J]. MOLECULAR THERAPY, 2001, 3 (03) : 403 - 410
  • [7] Crook K, 1996, GENE THER, V3, P834
  • [8] De novo quantitative bisulfite sequencing using the pyrosequencing technology
    Dupont, JM
    Tost, J
    Jammes, H
    Gut, NG
    [J]. ANALYTICAL BIOCHEMISTRY, 2004, 333 (01) : 119 - 127
  • [9] Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis
    Ferrari, S
    Geddes, DM
    Alton, EWFW
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (11) : 1373 - 1393
  • [10] Freimark BD, 1998, J IMMUNOL, V160, P4580